G&S Capital »

Vertex Pharmaceuticals Incorporated shares owned by G&S Capital

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by G&S Capital from 13F filings

Historical chart of G&S Capital investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by G&S Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by G&S Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $510k 1.3k 402.70
2024-09-30 $304k 653 465.08
2024-06-30 $321k 653 490.85
2024-03-31 $288k 689 418.01
2023-12-31 $284k 697 406.89
2023-09-30 $294k 846 347.74
2023-06-30 $298k 846 351.91
2023-03-31 $422k 1.3k 315.07
2022-12-31 $406k 1.4k 288.78
2020-06-30 $309k 1.1k 290.69

More positions owned by G&S Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Spdr Ser Tr Portfoli S&p1500 (SPTM)
Vanguard Index Fds Value Etf (VTV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Ishares Tr Core S&p Scp Etf (IJR)
Procter & Gamble Company (PG)
Capital Group Intl Focus Eqt Shs Creation Uni (CGXU)
Apple (AAPL)
Chevron Corporation (CVX)
Spdr Ser Tr Portfolio S&p400 (SPMD)
Invesco Exch Traded Fd Tr Ii S&p500 Low Vol (SPLV)
Abbvie (ABBV)
JPMorgan Chase & Co. (JPM)

View all positions for G&S Capital

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
State Street Corporation
FMR
Capital Research Global Investors
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Jennison Associates
Amundi
Loomis, Sayles and
Massachusetts Financial Services
Bank of America Corporation

View all funds holding Vertex Pharmaceuticals Incorporated